120 related articles for article (PubMed ID: 10762753)
1. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells.
Kirschke H; Eerola R; Hopsu-Havu VK; Brömme D; Vuorio E
Eur J Cancer; 2000 Apr; 36(6):787-95. PubMed ID: 10762753
[TBL] [Abstract][Full Text] [Related]
2. Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth.
Weber E; Günther D; Laube F; Wiederanders B; Kirschke H
J Cancer Res Clin Oncol; 1994; 120(9):564-7. PubMed ID: 8045924
[TBL] [Abstract][Full Text] [Related]
3. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts.
Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088
[TBL] [Abstract][Full Text] [Related]
4. Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts.
Denhardt DT; Greenberg AH; Egan SE; Hamilton RT; Wright JA
Oncogene; 1987; 2(1):55-9. PubMed ID: 3438085
[TBL] [Abstract][Full Text] [Related]
5. Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines.
Maciewicz RA; Wardale RJ; Etherington DJ; Paraskeva C
Int J Cancer; 1989 Mar; 43(3):478-86. PubMed ID: 2647640
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS
Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.
Krueger S; Haeckel C; Buehling F; Roessner A
Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype.
Krueger S; Kellner U; Buehling F; Roessner A
Cancer Gene Ther; 2001 Jul; 8(7):522-8. PubMed ID: 11498774
[TBL] [Abstract][Full Text] [Related]
9. Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts.
Ravanko K; Järvinen K; Helin J; Kalkkinen N; Hölttä E
Cancer Res; 2004 Dec; 64(24):8831-8. PubMed ID: 15604241
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment.
Rousselet N; Mills L; Jean D; Tellez C; Bar-Eli M; Frade R
Cancer Res; 2004 Jan; 64(1):146-51. PubMed ID: 14729618
[TBL] [Abstract][Full Text] [Related]
11. Expression of cysteine proteases in extraembryonic tissues during mouse embryogenesis.
Sol-Church K; Shipley J; Beckman DA; Mason RW
Arch Biochem Biophys; 1999 Dec; 372(2):375-81. PubMed ID: 10600178
[TBL] [Abstract][Full Text] [Related]
12. Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells.
Frade R; Rodrigues-Lima F; Huang S; Xie K; Guillaume N; Bar-Eli M
Cancer Res; 1998 Jul; 58(13):2733-6. PubMed ID: 9661883
[TBL] [Abstract][Full Text] [Related]
13. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
14. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts.
Achkar C; Gong QM; Frankfater A; Bajkowski AS
J Biol Chem; 1990 Aug; 265(23):13650-4. PubMed ID: 2166039
[TBL] [Abstract][Full Text] [Related]
15. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.
Levicar N; Dewey RA; Daley E; Bates TE; Davies D; Kos J; Pilkington GJ; Lah TT
Cancer Gene Ther; 2003 Feb; 10(2):141-51. PubMed ID: 12536203
[TBL] [Abstract][Full Text] [Related]
16. Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly.
Baer GS; Ebert DH; Chung CJ; Erickson AH; Dermody TS
J Virol; 1999 Nov; 73(11):9532-43. PubMed ID: 10516062
[TBL] [Abstract][Full Text] [Related]
17. Differential expression patterns of cathepsins B, H, K, L and S in the mouse ovary.
Oksjoki S; Söderström M; Vuorio E; Anttila L
Mol Hum Reprod; 2001 Jan; 7(1):27-34. PubMed ID: 11134357
[TBL] [Abstract][Full Text] [Related]
18. The malignant phenotype and cysteine proteinases.
Sloane BF; Rozhin J; Krepela E; Ziegler G; Sameni M
Biomed Biochim Acta; 1991; 50(4-6):549-54. PubMed ID: 1801721
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions.
Liuzzo JP; Petanceska SS; Moscatelli D; Devi LA
Mol Med; 1999 May; 5(5):320-33. PubMed ID: 10390548
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers.
Takahashi H; Ishidoh K; Muno D; Ohwada A; Nukiwa T; Kominami E; Kira S
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1562-8. PubMed ID: 8503570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
